Because an enhanced xCT expression is associated to an increase in extracellular glutamate in monocytes in vitro, the increase in glutamate transporter expression could be an adaptive response to counteract the excess of glutamate driven by xCT in MS. This evidence concerns the gene SLC7A11 and myeloid sarcoma.